Liposomes and ISCOMs

Vaccine

Volumn 21, Issue 9-10, 2003, Pages 915-920

  Kersten, Gideon F A ^a   Crommelin, Daan J A ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

ISCOMs; Liposomes; Virosomes

Indexed keywords

ALGINIC ACID; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; ARCHEAOSOME; CALCIUM PHOSPHATE; CHITOSAN; DRUG VEHICLE; FREUND ADJUVANT; IMMUNOLIPOSOME; IMMUNOLOGICAL ADJUVANT; INORGANIC SALT; ISCOM; LIPOSOME; MACROGOL; MEMBRANE ANTIGEN; MICROSPHERE; MONTANIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; NIOSOME; PROTEASOME; QUIL A; SAPONIN; TRANSFERSOME; UNCLASSIFIED DRUG; VACCINE; VIROSOME; WATER;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG MANUFACTURE; DRUG TARGETING; EMULSION; HUMAN; IMMUNOGENICITY; NONHUMAN; PHOSPHOLIPID BILAYER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLUBILITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; B-LYMPHOCYTES; HUMANS; ISCOMS; LIPOSOMES; MICROSCOPY, ELECTRON; MOLECULAR STRUCTURE; SAPONINS; T-LYMPHOCYTES; VACCINES; VIROSOMES;

EID: 0037435928     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00540-6     Document Type: Conference Paper

References (30)

1. Chang M.F., Shi Y., Nail S.L.et al. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits. Vaccine. 19:2001;2884-2889.
2. Kersten G.F.A., Crommelin D.J.A. Liposomes and ISCOMs as vaccine formulations. Biochim. Biophys. Acta. 1241:1995;117-138.
3. Barr I.G., Mitchell G.F. ISCOMs (immunostimulating complexes): the first decade. Immunol. Cell Biol. 74:1996;8-25.
4. Barr I.G., Sjolander A., Cox J.C. ISCOMs and other saponin based adjuvants. Adv. Drug Delivery Rev. 32:1998;247-271.
5. Lowell G.H., Kaminski R.W., Vancott T.C.et al. Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG. J. Infect. Dis. 175:1997;292-301.
6. Gluck R. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs). Vaccine. 17:1999;1782-1787.
7. Paul A., Cevc G. Noninvasive administration of protein antigens: immunization with BSA in transfersomes. Vaccine Res. 4:1995;145-164.
8. Patel G.B., Sprott G.D. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit. Rev. Biotechnol. 19:1999;317-357.
9. Krishnan L., Dicaire C.J., Patel G.B., Sprott G.D. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect. Immun. 68:2000;54-63.
10. Conlan J.W., Krishnan L., Willick G.E., Patel G.B., Sprott G.D. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes. Vaccine. 19:2001;3509-3517.
11. Brewer J.M., Alexander J. Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control. Vaccine. 12:1994;613-619.
12. Gupta R.K., Varanelli C.L., Griffin P., Wallach D.F.H., Siber G.C. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. Vaccine. 14:1996;219-225.
13. Brewer J.M., Alexander J. The adjuvant activity of non-ionic surfactant vesicles (Niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology. 75:1992;570-575.
14. Gould-Fogerite S., Kheiri M.T., Zhang F.et al. Targeting immune response induction with cochleate and liposome-based vaccines. Adv. Drug Delivery Rev. 32:1998;273-287.
15. Lowell G.H., Smith L.F., Seid R.C., Zollinger W.D. Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. J. Exp. Med. 167:1988;658-663.
16. Dalsgaard K. A study of the isolation and characterisation of the saponin Quil A. Acta Vet. Scand. Suppl. 69:1978;1-40.
17. Kersten G.F.A., Spiekstra A., Beuvery E.C., Crommelin D.J.A. On the structure of immune-stimulating saponin-lipid complexes (ISCOMs). Biochim. Biophys. Acta. 1062:1991;165-171.
18. Windon R.G., Chaplin P.J., McWaters P.et al. Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOM-matrix. Vaccine. 20:2002;490-497.
19. Copland M.J., Rades T., Davies N.M. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes. Int. J. Pharm. 196:2000;135-139.
20. Higuchi R., Tokimitsu Y., Komori T. An acylated triterpenoid saponin from Quillaja saponaria. Phytochemistry. 27:1988;1165-1168.
21. van Setten D. Multiple-stage tandem mass spectrometry implemented in the structure elucidation of Quil A saponins. Thesis, University of Utrecht, The Netherlands; 1999.
22. Stittelaar K.J., Boes J., Kersten G.F.A.et al. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components. Vaccine. 18:2000;2482-2493.
23. Steeghs L., Kuipers B., Hamstra H.J., Kersten G., van Alphen L., van der Ley P. Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response. Infect. Immun. 67:1999;4988-4993.
24. Kensil C. Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst. 13:1996;1-55.
25. Mowat A.M., Donachie A.M. ISCOMS - a novel strategy for mucosal immunization. Immunol. Today. 12:1991;383-385.
26. Behboudi S., Morein B., Villacres-Eriksson M. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids. Clin. Exp. Immunol. 105:1996;26-30.
27. Bergstrom-Mollaoglu M., Lovgren K., Akerblom L. Antigen-specific increases in the number of splenocyttes expressing MHC class II molecules following restimulation with antigen in various physical forms. Scand. J. Immunol. 36:1992;565-574.
28. Dotsika E., Karagouni E., Sundquist B., Morein B., Morgan A., Villacres-Eriksson M. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus ISCOMs. Scand. J. Immunol. 45:1997;261-268.
29. Maloy K.J., Donachie A.M., Mowat A.M. Induction of Th1 and Th2 CD4(+) T cell responses by oral or parenteral immunization with ISCOMS. Eur. J. Immunol. 25:1995;2835-2841.
30. Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., Berzofsky J.A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 344:1990;873-875.